A new offer builder tool aims to help founders support executives transitioning to fractional roles, improving packaging, pricing, and client acquisition.
How Founders Can Use Offer Builders To Support Fractional Executives
Browsing Category
General
349 posts
Food Recalls And Trends: Uninspected Beef, Pork, And Goat Under The Spotlight
Recent food recalls involving uninspected beef, pork, and goat highlight ongoing safety concerns. This report details confirmed facts and emerging issues.
Palisade Bio Receives FDA Clearance Of IND For PALI-2108 In Crohn’s Disease, Expanding Phase 2 Development Across IBD
Palisade Bio has received FDA clearance to proceed with Phase 2 trials of PALI-2108 for Crohn’s disease, advancing its development in inflammatory bowel disease.
Boris Vujčić: Interview With Reuters
Coverage interest is surging around a Boris Vujčić interview with Reuters. Content is unconfirmed, but ECB policy signals may be the draw.
How to Choose Halloween-Themed Financial Planning Tools
Create festive, themed financial planning tools to make budgeting and saving fun for Halloween. Follow this step-by-step guide for engaging results.
The Economic Outlook And Some Comments On My Policy Communication
Analysis of recent economic outlook and comments on policy communication, based on BIS trend signals and current market interest.
Reviving Historic Battles: AI And The 1693 La Citadelle Siege Archive
AI-driven digital exhibit reconstructs the 1693 siege of La Citadelle, blending historical fidelity with artistic storytelling through innovative web technology.
Isabel Schnabel: Macroeconomic, Fiscal And Financial Stability In A Shock-prone World
ECB’s Isabel Schnabel emphasizes the challenges of maintaining macroeconomic, fiscal, and financial stability amid global shocks, highlighting ongoing risks and uncertainties.
Christine Lagarde: A New Age Of Capital: Growth, Sovereignty And AI
ECB President Christine Lagarde discusses a new era of capital emphasizing growth, national sovereignty, and artificial intelligence, signaling shifting priorities for global finance.
Roche’s Collaborator MediLink Announces Phase III Data For Tam-Peli Showing Significantly Improved Overall Survival In Chinese Patient Population With Relapsed Small-cell Lung Cancer
MediLink reports significant improvement in overall survival for relapsed small-cell lung cancer patients in China using Tam-Peli, a combination therapy developed with Roche.
